The global mastectomy reconstruction implants market, valued at USD 1.95 billion in 2022 and projected to reach USD 4.69 billion by 2033. This significant expansion underscores the increasing adoption of reconstruction implants following mastectomies, driven by rising awareness, advancements in implant technology, and enhanced access to breast reconstruction options.
Key Market Drivers
Several factors are contributing to the steady growth of the mastectomy reconstruction implants market:
- Growing Awareness and Acceptance of Post-Mastectomy Reconstruction: Rising awareness around reconstructive options post-mastectomy is empowering patients, contributing to the market’s expansion.
- Technological Advancements in Implant Materials and Design: Innovations in implant technology, including enhanced biocompatibility and natural appearance, are driving increased adoption.
- Increased Access to Reconstructive Procedures Globally: Greater availability of skilled professionals and healthcare facilities providing mastectomy reconstruction is making these options accessible to a broader population.
As the demand for post-mastectomy reconstruction solutions continues to grow, the mastectomy reconstruction implants market is set for strong expansion. FMI’s insights signal a promising outlook, with ongoing advancements in technology and patient empowerment leading to sustained market growth.
Mastectomy reconstruction implants are breast implants that are used to reconstruct the breast tissue after a mastectomy, which is a surgical procedure in which one or both breasts are removed due to cancer or other medical conditions. The implants are typically made of silicone or saline and are placed under the chest muscle or breast tissue to create a natural-looking breast shape.
Overall, the increasing incidence of breast cancer, the growing demand for cosmetic surgeries, and the availability of technologically advanced breast implants, will boost the market in the coming years.
For instance, In 12 November 2019, BellaSeno and Evonik collaborated to bring an advanced 3D-printed breast implant technology to market. This technology designed to improve quality of life for patients after breast reconstruction and augmentation.
Competitive Landscape
Key players in the market are focused on increase their product portfolio to strengthen their position in the market, and also to expand their footprint in emerging markets. The key strategy adopted by manufacturers to gain competitive edge in the market are the pricing strategies, market strategies, technological advancements, regulatory compliance and approvals of the products to expand their business.
For instance:
- In 2020, GC Aesthetics plc received approval from the FDA for its NaturaCel breast implants. These implants are designed to provide a natural look and feel for women undergoing breast reconstruction surgery.
- In 2020, Allergan, Inc. received approval for Natrelle Inspira SoftTouch breast implants from the USA Food and Drug Administration (FDA). These implants are designed to provide a softer feel and a more natural look for women who are undergoing breast reconstruction surgery.
Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in the mastectomy reconstruction implants market space, which are available in the full report
Key Companies Profiled
Mentor Worldwide LLC (Johnson & Johnson Services, Inc.); AbbVie Inc. (Allergan PLC); Hans Biomed Co., Ltd; Galderma SA; GC Aesthetics; POLYTECH Health & Aesthetics GmbH; Sintera Inc; PMT Corporation; Ideal Implant Inc; Groupe Sebbin SAS; Hologic, Inc; Guangzhou Wanhe Plastic Materials Co., Ltd; Establishment Labs S.A; RTI Surgical Holdings Inc.; Nagor Limited
Grab Your Complete Report Instantly
Key Segments Covered in Mastectomy Reconstruction Implant Industry Research
By Product:
- Two-Stage Implant Reconstruction (matrix (ADM))
- Prepectoral Breast Reconstruction Surgery
- Sub-pectoral Breast Reconstruction Surgery
- Direct-to-Implant Reconstruction
By End User:
- Hospitals
- Cosmetology Clinics
- Ambulatory Surgical Centers
- Medical Spas
By Region:
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Central Asia
- Russia & Belarus
- Balkan & Baltic Countries
- Middle East and Africa (MEA)
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube